Association of PD-L1 and PD-L2 expression and tumor-infiltrating lymphocytes in <i>BRAF</i> V600E-mutated metastatic colorectal cancer: GI-SCREEN <i>post-hoc</i> analysis.

ESMO Gastrointest Oncol · 2023 · PMC12836720 · PMID 41647731

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Among this subgroup, analysis of OS according to PD-L1 expression on TC or IC showed a trend toward longer OS for PD-L1+ than for PD-L1− in both the groups.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Association of PD-L1 and PD-L2 expression and tumor-infiltrating lymphocytes in &lt;i&gt;BRAF&lt;/i&gt; V600E-mutated metastatic colorectal cancer: GI-SCREEN &lt;i&gt;post-hoc&lt;/i&gt; analysis.

The sentences

Association of PD-L1 and PD-L2 expression and tumor-infiltrating lymphocytes in <i>BRAF</i> V600E-mutated metastatic colorectal cancer: GI-SCREEN <i>post-hoc</i> analysis.